Victory Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.99M Sell
81,627
-11,791
-13% -$865K ﹤0.01% 1256
2025
Q1
$10.7M Buy
93,418
+18,389
+25% +$2.1M 0.01% 1020
2024
Q4
$3.78M Buy
75,029
+33,206
+79% +$1.67M ﹤0.01% 1335
2024
Q3
$1.94M Buy
41,823
+13,787
+49% +$638K ﹤0.01% 1492
2024
Q2
$911K Sell
28,036
-6,810
-20% -$221K ﹤0.01% 1749
2024
Q1
$878K Sell
34,846
-11,885
-25% -$299K ﹤0.01% 1799
2023
Q4
$1.52M Sell
46,731
-32,358
-41% -$1.05M ﹤0.01% 1531
2023
Q3
$2.15M Sell
79,089
-99,896
-56% -$2.72M ﹤0.01% 1365
2023
Q2
$3.98M Sell
178,985
-2,345
-1% -$52.2K ﹤0.01% 1239
2023
Q1
$3.93M Buy
181,330
+4,744
+3% +$103K ﹤0.01% 1248
2022
Q4
$3.59M Buy
176,586
+54,762
+45% +$1.11M ﹤0.01% 1279
2022
Q3
$3.12M Sell
121,824
-4,664
-4% -$120K ﹤0.01% 1349
2022
Q2
$3.01M Sell
126,488
-5,582
-4% -$133K ﹤0.01% 1358
2022
Q1
$2.91M Sell
132,070
-2,149
-2% -$47.4K ﹤0.01% 1391
2021
Q4
$2.66M Buy
134,219
+3,326
+3% +$65.8K ﹤0.01% 1470
2021
Q3
$2.58M Buy
130,893
+77,404
+145% +$1.52M ﹤0.01% 1511
2021
Q2
$1.18M Buy
53,489
+2,093
+4% +$46K ﹤0.01% 1836
2021
Q1
$1.22M Sell
51,396
-18,520
-26% -$441K ﹤0.01% 1826
2020
Q4
$1.83M Sell
69,916
-47,477
-40% -$1.24M ﹤0.01% 1552
2020
Q3
$2.04M Buy
117,393
+944
+0.8% +$16.4K ﹤0.01% 1435
2020
Q2
$1.96M Sell
116,449
-41,731
-26% -$702K ﹤0.01% 1435
2020
Q1
$1.88M Buy
158,180
+90,947
+135% +$1.08M ﹤0.01% 1626
2019
Q4
$814K Buy
67,233
+8,146
+14% +$98.6K ﹤0.01% 1801
2019
Q3
$835K Buy
59,087
+54,549
+1,202% +$771K ﹤0.01% 1734
2019
Q2
$51K Sell
4,538
-7,883
-63% -$88.6K ﹤0.01% 1728
2019
Q1
$146K Sell
12,421
-6,835
-35% -$80.3K ﹤0.01% 1625
2018
Q4
$257K Buy
19,256
+752
+4% +$10K ﹤0.01% 1505
2018
Q3
$259K Buy
18,504
+9,416
+104% +$132K ﹤0.01% 1551
2018
Q2
$143K Buy
9,088
+1,247
+16% +$19.6K ﹤0.01% 1671
2018
Q1
$129K Buy
7,841
+1,725
+28% +$28.4K ﹤0.01% 1679
2017
Q4
$110K Buy
6,116
+532
+10% +$9.57K ﹤0.01% 1675
2017
Q3
$108K Buy
+5,584
New +$108K ﹤0.01% 1687